Goldman Sachs’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-986,518
| Closed | -$83.8M | – | 5759 |
|
|
2019
Q4 | $83.8M | Buy |
986,518
+355,944
| +56% | +$23.7M | 0.02% | 812 |
|
|
2019
Q3 | $31.5M | Sell |
630,574
-221,357
| -26% | -$8.83M | 0.01% | 1437 |
|
|
2019
Q2 | $31.1M | Buy |
851,931
+151,224
| +22% | +$4.94M | 0.01% | 1505 |
|
|
2019
Q1 | $19.6M | Buy |
700,707
+15,766
| +2% | +$372K | 0.01% | 1890 |
|
|
2018
Q4 | $13.1M | Buy |
684,941
+240,392
| +54% | +$5.59M | ﹤0.01% | 2142 |
|
|
2018
Q3 | $13.3M | Sell |
444,549
-305,015
| -41% | -$11.5M | ﹤0.01% | 2234 |
|
|
2018
Q2 | $27.5M | Buy |
749,564
+35,915
| +5% | +$1.17M | 0.01% | 1649 |
|
|
2018
Q1 | $23.5M | Sell |
713,649
-272,155
| -28% | -$8.5M | 0.01% | 1733 |
|
|
2017
Q4 | $27M | Sell |
985,804
-2,074,755
| -68% | -$63.9M | 0.01% | 1721 |
|
|
2017
Q3 | $113M | Buy |
3,060,559
+913,478
| +43% | +$33.7M | 0.03% | 734 |
|
|
2017
Q2 | $81.6M | Buy |
2,147,081
+76,802
| +4% | +$3.42M | 0.02% | 907 |
|
|
2017
Q1 | $101M | Buy |
2,070,279
+1,364,302
| +193% | +$62.2M | 0.03% | 747 |
|
|
2016
Q4 | $24M | Buy |
705,977
+67,304
| +11% | +$2.39M | 0.01% | 1838 |
|
|
2016
Q3 | $24.1M | Buy |
638,673
+345,752
| +118% | +$13M | 0.01% | 1747 |
|
|
2016
Q2 | $9.85M | Buy |
292,921
+8,712
| +3% | +$307K | ﹤0.01% | 2332 |
|
|
2016
Q1 | $9.03M | Buy |
284,209
+179,910
| +172% | +$5.88M | ﹤0.01% | 2298 |
|
|
2015
Q4 | $3.89M | Sell |
104,299
-234,557
| -69% | -$8.86M | ﹤0.01% | 3068 |
|
|
2015
Q3 | $12.9M | Sell |
338,856
-167,197
| -33% | -$5.87M | ﹤0.01% | 2049 |
|
|
2015
Q2 | $14.5M | Buy |
506,053
+38,845
| +8% | +$1.08M | ﹤0.01% | 2055 |
|
|
2015
Q1 | $13.1M | Buy |
467,208
+134,408
| +40% | +$3.78M | ﹤0.01% | 2076 |
|
|
2014
Q4 | $9.21M | Buy |
332,800
+64,173
| +24% | +$1.59M | ﹤0.01% | 2415 |
|
|
2014
Q3 | $6M | Sell |
268,627
-145,431
| -35% | -$3.69M | ﹤0.01% | 2831 |
|
|
2014
Q2 | $12M | Sell |
414,058
-26,713
| -6% | -$713K | ﹤0.01% | 2220 |
|
|
2014
Q1 | $12.5M | Buy |
440,771
+94,048
| +27% | +$3.11M | ﹤0.01% | 2159 |
|
|
2013
Q4 | $13.4M | Buy |
346,723
+61,210
| +21% | +$2.19M | ﹤0.01% | 2093 |
|
|
2013
Q3 | $9.57M | Buy |
285,513
+128,268
| +82% | +$4.09M | ﹤0.01% | 2304 |
|
|
2013
Q2 | $4.84M | Buy |
+157,245
| New | +$5.26M | ﹤0.01% | 2777 |
|
Other funds holding MDCO
Goldman Sachs's MDCO Position: Q1 2020 in Review
Goldman Sachs sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 986,518 shares — an estimated $83.8M sold.
Goldman Sachs first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $113M in Q3 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Goldman Sachs reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Goldman Sachs sold 986,518 Medicines Co shares in Q1 2020, an estimated $83.8M.
- Goldman Sachs first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Goldman Sachs's Medicines Co position peaked at $113M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.